ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Ibrance 125 mg, Hartkapseln - 21
66138003 PPPfizer AG
Ibrance 125 mg, Hartkapseln31.01.2017
  31.01.2017
Palbociclib (L01EF01) 
WHO-DDD 
07.16.10.21
07.16.10. 
A  
Yes 
IPCI
1973.56Yes
    
10 %2162.80
  
7680661380036Synthetika
6967312 
Composition
palbociclibum 125 mg, cellulosum microcristallinum, lactosum monohydricum 92.958 mg, carboxymethylamylum natricum A, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 172 (rubrum), E 172 (flavum), E 171, Drucktinte: lacca, E 171, ammoniae solutio 28 per centum, propylenglycolum, simeticonum, pro capsula, natrium 2.13 mg.
Packungsbestandteile
Capsules 
 
Active AgentDose
Palbociclibum125 mg
BAG: Active AgentDose
Palbociclibum125 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Rubrum)  
Ammoniae Solutio28  
Carboxymethylamylum Natricum A  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Gelatina Kapselhülle
Lacca Drucktinte
Lactose Monohydrate92.958 mg 
Magnesii Stearas  
Sodium2.13 mg 
Per Centum  
Pro Capsula  
Propylenglycol  
Silica Colloidalis Anhydrica  
Simeticone  
 
Source
Data was imported : 06.07.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home